RxCap has filed a notice of an exempt offering of securities to raise $21,156,047.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, RxCap is raising up to $21,156,047.00 in new funding. Sources indicate that as part of senior management President, Sreeram Ramakrishnan played a key role in…